Gilead: AIDS Activists
Are Not For Sale
Gilead is the poster child for drug company price gouging.
Gilead has doubled the price they charge to safety net providers for the prevention drug Descovy in just two years.
Gilead tries to cover its tracks by giving millions of dollars to the same AIDS organizations it has decimated.
Gilead should know by now that AIDS activists are not for sale.
Gilead must immediately restore the money they have taken from AIDS organizations.
Gilead: AIDS Activists
Are Not For Sale
Gilead is the poster child for drug company price gouging.
Gilead has doubled the price they charge to safety net providers for the prevention drug Descovy in just two years.
Gilead tries to cover its tracks by giving millions of dollars to the same AIDS organizations it has decimated.
Gilead should know by now that AIDS activists are not for sale.
Gilead must immediately restore the money they have taken from AIDS organizations.
Take action today. Follow the link below to take a stand against corporate greed.
AHF Protests Against Gilead
AHF TAKES A STAND
Gilead has priced several of its HIV and hepatitis C drugs out of reach for many people, refused to register some medications in developing countries, and consistently uses its patent monopolies to block attempts to introduce cheaper, generic versions of its medicines.
AHF is taking its grassroots campaign global to raise awareness about Gilead’s shameful practices and calling on the company to do the following:
- Stop evergreening patents on existing HIV/AIDS drugs like Truvada – this is exploitation, not innovation.
- Open the license for the generic production of the hepatitis C drug Harvoni to all low- and middle-income countries, without exception.
- For the duration of the COVID-19 pandemic, sell or license remdesivir for generic distribution at a nonprofit price.
- License technology to produce cryptococcal meningitis to generic manufacturers.
- Link executive compensation to the impact on positive public health outcomes and access to medicines in developing countries.
Get The Facts
Get The Facts
Miles de personas en América Latina mueren por enfermedades curables porque @GileadSciences fija precios con hasta 1000% de utilidad a medicamentos que salvan vidas. Es hora de poner un ALTO a la avaricia, porque la avaricia mata. #STOPGILEAD #GreedyGilead #PharmaGreed
Our advocates are protesting at the Leerink Partners Global Biopharma Conference at the Fontainebleau Miami Beach Hotel where @GileadSciences is again trying to woo investors. We're reminding those investors about #GreedyGilead's ongoing efforts to rack up exorbitant profits…
How appropriate! The CEO of @GileadSciences - the poster child for pharma greed - is now atop the fortress of pharma greed.
#GreedyGilead #GreedyPharma
Daniel O’Day of Gilead Sciences Becomes New Chair of PhRMA Board https://www.phrma.org/resource-center/Topics/Press-Release/Daniel-O-Day-New-Chair-of-PhRMA-Board
It is about time @GileadSciences is made to pay for the lives they have ruined with their relentless greed.
In a first-of-its-kind ruling, the California First District Court of Appeals in San Francisco ruled that pharma giant #GreedyGilead can be held liable by 24,000 #AIDS…
AIDS Healthcare Foundation 2024